![Holger Wesche](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Holger Wesche
Directeur Technique/Scientifique/R&D chez
HARPOON THERAPEUTICS, INC.
Profil
Holger Wesche is currently the Chief Scientific Officer at Harpoon Therapeutics, Inc. He previously worked as a Scientific Director at Amgen, Inc. from 2013 to 2015.
He obtained a doctorate degree from the University of Hannover.
Postes actifs de Holger Wesche
| Sociétés | Poste | Début |
|---|---|---|
| HARPOON THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/10/2018 |
Anciens postes connus de Holger Wesche
| Sociétés | Poste | Fin |
|---|---|---|
| AMGEN INC. | Directeur Technique/Scientifique/R&D | 01/04/2015 |
Formation de Holger Wesche
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
67
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
University of Hannover
 University of Hannover Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases | Health Technology |
